Fibromyalgia Podcast

Have you been hearing the buzz about the new medication approved for the treatment of fibromyalgia? Fibromyalgia can come with a myriad of symptoms that make everyday life more difficult. With the limited pharmaceutical options available, the addition of another FDA-approved medication is a ray of hope. Tonmya™ is the first medication approved for fibromyalgia in over 15 years, promising a new option for those of us with fibromyalgia. Today, Tami is joined by Dr. Seth Lederman, one of the co-founders of the company that developed Tonmya™, to talk about the journey from idea to FDA approval and what it could mean for the fibromyalgia community. With decades of experience in rheumatology, immunology, and drug development, Dr. Lederman has been focused on helping people with fibromyalgia for much of his career. In this conversation, Tami and Dr. Lederman discuss his medical and research background, why he focused on fibromyalgia, advances in fibromyalgia research, the FDA approval process, why Tonmya™ targets no